Study start-up is where timelines compress and costs escalate. Between protocol finalisation, informed consent form development, regulatory submission packaging, and site feasibility documentation, the average UK Phase I–II study generates 15–25 regulatory-grade documents before a single patient is screened.
At DEOX, we have built an AI-assisted document production pipeline that reduces this cycle by approximately 40% — without compromising GxP compliance, regulatory quality, or human oversight.
The bottleneck: manual document workflows
In a traditional CRO model, each regulatory document follows a linear workflow: template identification, first-draft writing, internal review, QC check, and sponsor approval. For a typical UK CTA submission package:
- Protocol — 4–6 weeks from concept to final
- Informed Consent Forms — 2–3 weeks per site template
- Investigator Brochure — 3–5 weeks with source data integration
- Regulatory cover letters and submission forms — 1–2 weeks
These timelines are sequential, labour-intensive, and assume each draft will require 2–3 review cycles. The cumulative effect is a 12–18 week start-up window from protocol concept to MHRA acknowledgement.
How AI assistance changes the equation
Our pipeline uses enterprise-grade, BAA-covered frontier AI models to accelerate the first-draft and formatting stages while keeping every substantive review and approval step fully human. Here is how it works in practice:
1. Context ingestion
The AI processes the sponsor's existing documentation — IND data, preclinical reports, investigator brochures, and protocol outlines. It extracts key safety data, dosing rationale, eligibility criteria, and endpoint structures into a structured knowledge layer.
2. Template-driven generation
Using DEOX's library of 30+ GxP-aligned SOPs and document templates, the AI generates first drafts that already conform to the correct structure, formatting, and regulatory requirements. This includes MHRA submission formatting, HRA ethics requirements, and ICH GCP alignment.
3. Human review and approval
Every AI-generated draft routes to a qualified DEOX clinical professional for substantive review. The AI handles structure, formatting, and consistency. The human handles clinical judgement, sponsor-specific nuance, and final approval. No document is finalised without human sign-off.
4. Automated QC
Our automated QC pipeline scans finalised documents for consistency, completeness, cross-reference accuracy, and regulatory formatting compliance. It flags issues before they reach the sponsor, reducing review cycles.
Every AI output in our pipeline is logged, versioned, and auditable. We use enterprise AI with Business Associate Agreements, SOC 2 Type II certification, and a zero data retention policy. No sponsor data is used for model training. Our full AI governance framework is documented in our QMS and available for sponsor audit.
What this means for sponsors
The practical impact of AI-assisted document production is measurable across three dimensions:
- Speed: First drafts produced in hours, not weeks. Start-up timelines compressed from 12–18 weeks to 7–11 weeks.
- Consistency: Template-driven generation eliminates the formatting drift, cross-reference errors, and structural inconsistencies that plague manually-written regulatory documents.
- Cost: Less professional writing time per document translates directly to lower project costs. Combined with DEOX's lean operating model, sponsors typically see 45–55% savings versus Big CRO rates.
What AI does not replace
AI assistance does not replace clinical judgement, regulatory strategy, or the sponsor relationship. Specifically:
- Clinical decision-making remains with qualified professionals
- Regulatory strategy is set by experienced DEOX regulatory leads
- Sponsor communication is always direct, senior-level, and human
- Final document approval requires human sign-off on every output
The AI is a force multiplier for our team — not a substitute for it.
Our QC pipeline runs automatically
Beyond document generation, DEOX operates an automated QC pipeline that continuously scans the entire QMS document repository. The pipeline checks for:
- Document version consistency across the QMS
- Cross-reference accuracy between SOPs, tools, and forms
- Formatting compliance with regulatory templates
- Completeness of required QMS elements (signatures, dates, version history)
- Orphaned or unlinked documents
In our first production run, the pipeline scanned 781 QMS documents and generated a full compliance dashboard in under 60 seconds. This kind of continuous, automated quality monitoring is not feasible with manual processes alone.